ACLX Q1 2024 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M+119.2% YoY

Gross Profit

$38M97.9% margin

Operating Income

-$16M-40.3% margin

Net Income

-$7M-18.3% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-37.8%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$38M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$780M

Total Liabilities

$283M

Stockholders' Equity

$497M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$18M	+119.2%
Gross Profit	$38M	$17M	+123.8%
Operating Income	-$16M	-$30M	+48.1%
Net Income	-$7M	-$27M	+73.7%